SCHEMBL6609347

SCHEMBL6609347

NC(=O)c1sc(-c2ccc(Cl)s2)cc1N

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 8/20 0.64
CYP1A2 P05177 2/20 0.58
CYP3A4 P08684 2/20 0.58
CYP2C9 P11712 2/20 0.58
BTK Q06187 1/20 0.58
CDC7 O00311 1/20 0.55
DBF4 Q9UBU7 1/20 0.55
CHUK O15111 1/20 0.55
CYP2C19 P33261 1/20 0.55
MAPT P10636 7/20 0.54
ALDH1A1 P00352 4/20 0.54
HDAC6 Q9UBN7 1/20 0.54
F2 P00734 1/20 0.48
POLB P06746 1/20 0.46
KDM4E B2RXH2 5/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
GFER P55789 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607677 0.81 CDC7 (0.58) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL4097325 0.78 IKBKB (1.00) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL12247521 0.77 IKBKB (0.56) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL6607919 0.77 IKBKB (0.56) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL6607364 0.76 IKBKB (0.72) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL4082681 0.76 IKBKB (0.62) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL4087590 0.75 MAPT (0.68) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL4086753 0.74 IKBKB (0.75) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL6612593 0.74 IKBKB (0.76) IKBKBCYP1A2CYP3A4CYP2C9BTK
SCHEMBL1847243 0.74 IKBKB (1.00) IKBKBCYP1A2CYP3A4CYP2C9BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444010-A2 HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2004-08-11 EP claimed
WO-2003037886-A2 HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-05-08 WO claimed
EP-1444010-A2 HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2004-08-11 EP disclosed
WO-2003037886-A2 HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-05-08 WO disclosed